Tranexamic Acid in Nasal Mohs Reconstruction

NCT06057675 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Postoperative Bleeding
Skin Cancer Face

Interventions

DRUG: Treatment (tranexamic acid and 1% lidocaine with 1:100,000 epinephrine)
DRUG: Control (1% lidocaine with 1:100,000 epinephrine)

Sponsor

Vanderbilt University Medical Center